Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Study of the Efficacy of PedyPhar® Ointment on the Diabetic Foot Ulcers (PED111)

This study has been terminated.
(inability to recruit patients)
Sponsor:
Information provided by (Responsible Party):
European Egyptian Pharmaceutical Industries
ClinicalTrials.gov Identifier:
NCT01531517
First received: February 6, 2012
Last updated: February 19, 2015
Last verified: February 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2013
  Primary Completion Date: July 2012 (Final data collection date for primary outcome measure)